These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


97 related items for PubMed ID: 772604

  • 21. [Letter: Acute hyperuricemic kidney failure. Treatment by uricozyme].
    Chanteclair G, Olive D.
    Nouv Presse Med; 1975 Sep 27; 4(31):2274. PubMed ID: 1178498
    [No Abstract] [Full Text] [Related]

  • 22. Comparison of the urate lowering effects of allopurinol and diflunisal.
    Emmerson BT, Hazelton RA, Whyte IM.
    J Rheumatol; 1987 Apr 27; 14(2):335-7. PubMed ID: 3599002
    [Abstract] [Full Text] [Related]

  • 23. [Modern therapy of gout].
    Delbarre F, Saporta L, De Gery A, Panahi F.
    Clin Ter; 1968 Jul 31; 46(2):103-22. PubMed ID: 5704842
    [No Abstract] [Full Text] [Related]

  • 24. Pegloticase (krystexxa) for treatment of refractory gout.
    Med Lett Drugs Ther; 2011 Feb 07; 53(1357):9-10. PubMed ID: 21304442
    [No Abstract] [Full Text] [Related]

  • 25. [The effect of fructose on uric acid metabolism].
    Holländer E.
    Acta Med Acad Sci Hung; 1974 Feb 07; 31(3-4):147-55. PubMed ID: 4469712
    [No Abstract] [Full Text] [Related]

  • 26. [Prevention of hyperuricemia and its complications with allopurinol, in the treatment of several hematologic diseases].
    Rapado Errazti A, Torres González JA.
    Rev Clin Esp; 1966 Nov 30; 103(4):296-301. PubMed ID: 5999583
    [No Abstract] [Full Text] [Related]

  • 27. Optimizing therapy with allopurinol: factors limiting hypouricemic efficacy.
    Chung Y, Stocker SL, Graham GG, Day RO.
    Am J Med Sci; 2008 Mar 30; 335(3):219-26. PubMed ID: 18344696
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Refractory gout: what is it and what to do about it?
    Fels E, Sundy JS.
    Curr Opin Rheumatol; 2008 Mar 30; 20(2):198-202. PubMed ID: 18349751
    [Abstract] [Full Text] [Related]

  • 31. [Action of 8 129 CB (urate oxidase) on retinal manifestations of hyperuricemia].
    Algan B.
    Bull Soc Belge Ophtalmol; 1971 Mar 30; 158():432-6. PubMed ID: 5144767
    [No Abstract] [Full Text] [Related]

  • 32. [Urate oxidase in pediatrics].
    Dumas R, Castel J, Jean R.
    Pathol Biol (Paris); 1973 Apr 30; 21(4):425-9. PubMed ID: 4576180
    [No Abstract] [Full Text] [Related]

  • 33. A comparative study on the hypouricemic activity and potency in renal xanthine calculus formation of two xanthine oxidase/xanthine dehydrogenase inhibitors: TEI-6720 and allopurinol in rats.
    Horiuchi H, Ota M, Kobayashi M, Kaneko H, Kasahara Y, Nishimura S, Kondo S, Komoriya K.
    Res Commun Mol Pathol Pharmacol; 1999 Apr 30; 104(3):307-19. PubMed ID: 10741381
    [Abstract] [Full Text] [Related]

  • 34. [Drug therapy of hyperuricemia].
    Gröbner W.
    Verh Dtsch Ges Inn Med; 1986 Apr 30; 92():492-7. PubMed ID: 3811551
    [No Abstract] [Full Text] [Related]

  • 35. Effect of allopurinol versus urate oxidase on methotrexate pharmacokinetics in children with newly diagnosed acute lymphoblastic leukemia.
    Crews KR, Zhou Y, Pauley JL, Howard SC, Jeha S, Relling MV, Pui CH.
    Cancer; 2010 Jan 01; 116(1):227-32. PubMed ID: 19834958
    [Abstract] [Full Text] [Related]

  • 36. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP, Leung KT, Tong MK, Kwan TH.
    Am J Kidney Dis; 2006 Jan 01; 47(1):51-9. PubMed ID: 16377385
    [Abstract] [Full Text] [Related]

  • 37. Treatment of hyperuricemia in essential hypertension.
    Trachtman H.
    Hypertension; 2007 Jun 01; 49(6):e45; author reply e46. PubMed ID: 17389252
    [No Abstract] [Full Text] [Related]

  • 38. Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Torres RJ, Prior C, Puig JG.
    Metabolism; 2007 Sep 01; 56(9):1179-86. PubMed ID: 17697859
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.